Symtuza® (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide)
for Human Immunodeficiency Virus

Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) is a once-daily HIV treatment that combines four medicines: darunavir, cobicistat, emtricitabine, and tenofovir alafenamide. Darunavir, emtricitabine, and tenofovir work to stop HIV from multiplying, while cobicistat boosts darunavir's effectiveness by slowing its breakdown in the liver. Together, they help control HIV infection and support immune system health.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Human Immunodeficiency Virus - HIV